Abstract:Purpose: New serum biomarkers are needed to improve the early detection of colorectal adenocarcinoma. We performed surface enhanced laser desorption and ionization time-of-flight mass spectrometry (SELDI-TOF-MS) to screen for differentially expressed proteins in serum and build a proteomic diagnostic pattern for the detection of colorectal adenocarcinoma to improve the prognosis of patients with this disease. Experimental Design: In an attempt to improve current approaches to the serologic diagnosis of colorectal cancer, we analyzed serum samples from subjects with or without colorectal cancer using SELDI-MS. Using a case-control study design, SELDI-MS profile of serum samples from 74 colorectal adenocarcinoma patients were compared with 48 age-and sex-matched healthy subjects using a ProteinChip reader, PBSII-C. Proteomic MS spectra were generated using IMAC3 chips, and protein peaks clustering and classification analyses were performed to build a proteomic pattern that could differentiate patients with colorectal adenocarcinoma from healthy subjects utilizing Biomarker Wizard and Biomarker Patterns software packages, respectively. The constructed pattern was then used to test an independent set of masked serum samples from 60 colorectal cancer patients and 39 healthy subjects.Results: Among the differentially expressed protein peaks identified by SELDI-MS profiling that had the ability to distinguish between patients and healthy subjects, we determined a minimum set of two protein peaks for system training and for developing a decision classification pattern. Masked analysis of an independent set of serum samples showed the diagnostic pattern could differentiate patients with different stages of colorectal cancer from healthy subjects with a sensitivity of 95.00 percent and specificity of 94.87 percent. Conclusion: SELDI-TOF-MS profiling of serum proteins combined with bioinformatics tools can be applied to accurately differentiate patients with colorectal cancer from healthy subjects. The high sensitivity and specificity achieved by the constructed clustering analysis algorithm show great potential for the early detection of colorectal cancer.

Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry: serum protein profiling in seminoma patients

[Application of Saliva Protein Fingerprints in the Diagnosis of Oral Squamous Cell Cancer by Surface Enhanced Laser Desorption Ionization Time of Flight Mass].

Proteomic Diagnosis Models from Serum for Early Detection of Oral Squamous Cell Carcinoma.

[Use of Laser Capture Microdissection and Surface-Enhanced Laser Desorption Ionization Time-of-flight Mass Spectrometry to Screen Differential Proteins in Lung Adenocarcinoma and Lung Squamous Carcinoma].

Application of Surface-Enhanced Laser Desorption/ionization Time-of-flight-based Serum Proteomic Array Technique for the Early Diagnosis of Prostate Cancer

Diagnosis of pancreatic adenocarcinoma using protein chip technology.

A Serum Proteomic Pattern for the Detection of Colorectal Adenocarcinoma Using Surface Enhanced Laser Desorption and Ionization Mass Spectrometry

[Proteomic Analysis of Prostate Cancer Using Surface Enhanced Laser Desorption/ionization Mass Spectrometry].

Discovery of Serum Biomarkers in Astrocytoma by SELDI–TOF MS and Proteinchip Technology

Mass Spectrometric Analysis of Cerebrospinal Fluid Protein for Glioma and Its Clinical Application

Diagnostic Application of Serum Protein Pattern and Artificial Neural Network Software in Breast Cancer

Proteiomic Patterns for Endometrial Cancer Using SELDI-TOF-MS

Molecular and histopathological characterization of seminoma patients with highly elevated human chorionic gonadotropin levels in the serum

Limitations in Seldi-Tof Ms Whole Serum Proteomic Profiling with Imac Surface to Specifically Detect Colorectal Cancer

Serum Protein Fingerprinting Coupled with Artificial Neural Network Distinguishes Glioma from Healthy Population or Brain Benign Tumor

Preoperatively Molecular Staging with CM10 ProteinChip and SELDI-TOF-MS for Colorectal Cancer Patients

[Establishment of serum protein pattern model for screening pancreatic cancers by SELDI-TOF-MS technique]

SELDI-TOF MS profiling of serum for detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis

Establishment of Diagnostic Model of Cerebrospinal Protein Fingerprint Pattern for Glioma and Its Clinical Application

Proteomic Studies of Early-Stage and Advanced Ovarian Cancer Patients.

Serum protein fingerprinting coupled with artificial neural network distinguishes glioma from healthy population and brain benign tumo